12:00 AM
Mar 19, 2012
 |  BC Week In Review  |  Financial News  |  Other Financial News

Cytos financial update

Cytos Biotechnology AG (SIX:CYTN), Zurich, Switzerland
Business: Neurology, Inflammation, Cardiovascular
Date announced: 3/13/12
Cytos said its proposal to prevent the company from defaulting on the outstanding amount...

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >